Fundraising FoxSymeres
Netherlands, NL · 2 known investors
Find your way into Symeres
627 people in our graph share verified history with the Symeres team — schools, employers, funds. One of them is your warm intro.
Raffaele Fedeleunlockedknows Henning Steinhagen · together at Grünenthal Pharma (overlapped)
knows the team · via Libra Therapeutics
×9knows the team · via Epidarex Capital
knows the team · via Inflexion
Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.
Founders & leadership
HS
Henning SteinhagenChief Executive Officer (CEO)Henning Steinhagen has spent 25 years in pharmaceutical and biotech R&D, serving as former President of R&D at Aptuit (acquired by Evotec AG in 2017) and co-founder and former CEO of Lario Therapeutics, a UK-based precision medicine company. He holds an executive MBA from IMD Lausanne and currently serves as CEO of Symeres.
Investors · 2
In the news
Frequently asked questions
- What does Symeres do?
- Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.
- Who are Symeres's investors?
- Symeres's investors include Gilde Healthcare, Keensight Capital.
- Where is Symeres headquartered?
- Symeres is headquartered in Netherlands, NL.